Cargando…
SAT-570 Should Severe Hypertriglyceridemia Also Be Considered as a Contraindication for Use of Glucagon like Peptide 1 (GLP-1) Agonists?
Background: Reported cases of acute pancreatitis have been associated with the use of GLP-1 agonists for treatment of diabetes mellitus. Hypertriglyceridemia is a well-established but underestimated cause of acute and recurrent pancreatitis. At the present time, there is insufficient data to know if...
Autor principal: | Guzman, Amelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209679/ http://dx.doi.org/10.1210/jendso/bvaa046.242 |
Ejemplares similares
-
SAT-577 Severe Asymptomatic Hypertriglyceridemia
por: Rodriguez, Daniel, et al.
Publicado: (2020) -
SAT-569 Management of Severe Gestational Hypertriglyceridemia
por: Borja, Anne, et al.
Publicado: (2020) -
Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018) -
SAT-571 Rare Case of Tocilizumab-Induced Severe Hypertriglyceridemia
por: Modi, Ankur, et al.
Publicado: (2020) -
Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor
por: Helmstädter, Johanna, et al.
Publicado: (2021)